There are a vast number of diseases that affect patient health that at present do not have effective treatment options. A lot of existing therapies are designed to inhibit the adverse proteins that contribute to disease. What if we instead enhanced the power of beneficial proteins to help restore patient health — and in so doing, developed a new class of drugs capable of treating a broad range of diseases? Entact Bio approached Wunderdogs to help get their story out through a brand new visual identity and digital platform.
At the core of Entact Bio is technology that harnesses the cell's natural mechanism for enhancing protein function. With that process in mind we developed an identity that utilizes bold graphic shapes that represent different aspects of the technology, that come together in different ways to create a modular visual language. Our ambition was to build unique meaning into every aspect of the brand.
The Entact Bio logo was inspired by the innovative platform methodology the Entact Bio team brings to the development of new drugs that treat a broad range of diseases. The shapes of the logo are derived from an illustration the team shared with us that shows their process in action. It not only reflects the unique innovation but also connects the brand to the real life work the team is doing.
Entact Bio works at the forefront of cellular health; what they do is complex and detailed. Our task for the website was to convey this complexity in a simple way, helping users quickly understand their value and find what they need. Bold colors create impact while off whites give space to content, creating a balance that makes information easy to navigate. We incorporated the core shapes of the proteins in different combinations and as masks for imagery to provide a consistent look and feel and one that spoke to the potential of the team's technology.
In December 2022, Entact Bio launched with a new brand and a $81 million Series A to develop precision medicines for targeted protein enhancement.